E-mail

E-mail a Wiley Online Library Link

Andrew J. Vickers, Daniel D. Sjoberg, Donna P. Ankerst, Catherine M. Tangen, Phyllis J. Goodman and Ian M. Thompson Jr The Prostate Cancer Prevention Trial risk calculator and the relationship between prostate-specific antigen and biopsy outcome Cancer 119

Version of Record online: 29 MAY 2013 | DOI: 10.1002/cncr.28114

The Prostate Cancer Prevention Trial risk calculator is widely used to predict the risk of prostate cancer for men considering prostate biopsy. The risk calculator is demonstrated to overestimate risk, because it assumes that the relationship between prostate-specific antigen and risk is the same for low as for elevated prostate-specific antigen levels.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

SEARCH